The FDA recently approved a new Transcarotid Artery Revascularization (TCAR) procedure that utilizes the ENROUTE® Transcarotid Neuroprotection and Stent System from Silk Road Medical. The TCAR ...
World's First Transcarotid Stent Delivery System Designed for the Clinically Proven TransCarotid Artery Revascularization (TCAR) Procedure SUNNYVALE, Calif., Silk Road Medical, Inc. announced the ...
Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques SUNNYVALE, ...
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has ...
Please provide your email address to receive an email when new articles are posted on . A new tapered configuration of transcarotid stent system was launched in the U.S. The system indicated for ...
SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER ...
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of ...
Silk Road Medical, Inc. SILK recently announced the launch of its ENROUTE Transcarotid Neuroprotection System PLUS (NPS PLUS), which is a key component of the company’s Transcarotid Artery ...